It also describes factors that impact your lifespan and ways to cope with this severe condition. Life expectancy statistics for hATTR amyloidosis can provide key information about your disease ...

Background: Little is known about the long term prognosis for patients the severe acute motor axonal neuropathy (AMAN) form of Guillain–Barré syndrome (GBS), unlike those with acute inflammatory ...

The diagnosis of amyloidosis requires a tissue biopsy that demonstrates apple-green birefringence when stained with Congo Red and viewed with a polarizing microscope. Sulfate Alcian Blue is an ...

"In people with progressive cognitive decline, the diagnosis of Alzheimer's disease ... for other diseases except possible cerebral amyloid angiopathy, he said. Despite the questions raised ...

ALZ-801 is under development for the treatment of Alzheimer’s disease, cerebral amyloid angiopathy (CAA) and Down syndrome. The drug candidate is a prodrug of tramiprosate. It is a small molecule ...

Cite this: Steroid Responsive Encephalopathy in Cerebral Amyloid Angiopathy: A Case Report and Review of Evidence for Immunosuppressive Treatment - Medscape - Mar 01, 2010.

Cerebral proliferative angiopathy (CPA) is a rare vascular disorder that affects normal blood circulation in the brain. Although the structural changes in CPA can be characterized using standard ...

Dr Nair introduces a new video series surrounding identification of and key treatment strategies for Alzheimer disease.

Antibodies directed at the amyloid-β peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of brain edema or bleeding events, collectively ...

The risk of developing AL amyloidosis increases each decade after 40 years, with the median age of diagnosis at 64 years. Fewer than 5% of people with AL amyloidosis are under age 40. AL ...